Alx Oncology Holdings (ALXO) Change in Account Payables (2019 - 2026)
Alx Oncology Holdings' Change in Account Payables history spans 5 years, with the latest figure at -$4.5 million for Q4 2023.
- On a quarterly basis, Change in Account Payables fell 282.72% to -$4.5 million in Q4 2023 year-over-year; TTM through Dec 2023 was $458000.0, a 89.84% decrease, with the full-year FY2025 number at $421000.0, up 110.46% from a year prior.
- Change in Account Payables hit -$4.5 million in Q4 2023 for Alx Oncology Holdings, down from $8.9 million in the prior quarter.
- Over the last five years, Change in Account Payables for ALXO hit a ceiling of $8.9 million in Q3 2023 and a floor of -$5.7 million in Q2 2023.
- Historically, Change in Account Payables has averaged $389444.4 across 5 years, with a median of -$325000.0 in 2020.
- Biggest five-year swings in Change in Account Payables: plummeted 581.88% in 2021 and later skyrocketed 843.64% in 2022.
- Tracing ALXO's Change in Account Payables over 5 years: stood at $3.1 million in 2019, then crashed by 146.33% to -$1.4 million in 2020, then soared by 76.78% to -$330000.0 in 2021, then skyrocketed by 843.64% to $2.5 million in 2022, then crashed by 282.72% to -$4.5 million in 2023.
- Business Quant data shows Change in Account Payables for ALXO at -$4.5 million in Q4 2023, $8.9 million in Q3 2023, and -$5.7 million in Q2 2023.